Literature DB >> 17406586

The parallel rod floor test: a measure of ataxia in mice.

Helen M Kamens1, John C Crabbe.   

Abstract

The parallel rod floor test is a new model of ataxia in mice. It allows the simultaneous measurement of ataxia and locomotor activity. This protocol is designed for researchers examining ethanol-induced motor incoordination in mice, but it should be applicable to other sedative/hypnotic drugs and to testing cerebellar mutant mice or mice with engineered genetic defects. This protocol takes 3 d, with the time per day depending on how many animals are tested. The test allows researchers to quantify differences in motor coordination among genotypes of mice that may differ in locomotor activity. Unlike many other methods for assessing incoordination, the parallel rod floor test yields similar patterns of genetic sensitivity across a range of variant forms of the apparatus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406586     DOI: 10.1038/nprot.2007.19

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  21 in total

1.  The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.

Authors:  Liron Abuhatzira; Alon Shamir; Dustin E Schones; Alejandro A Schäffer; Michael Bustin
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

2.  Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.

Authors:  Beth A Smith; Natalie R S Goldberg; Charles K Meshul
Journal:  Brain Res       Date:  2011-03-21       Impact factor: 3.252

3.  Ethanol withdrawal-induced motor impairment in mice.

Authors:  Scott D Philibin; Andy J Cameron; Jason P Schlumbohm; Pamela Metten; John C Crabbe
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

Review 4.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

5.  Sensitization and Tolerance Following Repeated Exposure to Caffeine and Alcohol in Mice.

Authors:  Christina E May; Harold L Haun; William C Griffin
Journal:  Alcohol Clin Exp Res       Date:  2015-07-02       Impact factor: 3.455

6.  Assessment of ataxia phenotype in a new mouse model of galactose-1 phosphate uridylyltransferase (GALT) deficiency.

Authors:  Wyman Chen; Rose Caston; Bijina Balakrishnan; Anwer Siddiqi; Kamalpreet Parmar; Manshu Tang; Merry Feng; Kent Lai
Journal:  J Inherit Metab Dis       Date:  2016-10-25       Impact factor: 4.982

7.  Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Lacey Pflibsen; Katherine A Stang; Michelle D Sconce; Vanessa B Wilson; Rebecca L Hood; Charles K Meshul; Suzanne H Mitchell
Journal:  J Neurosci Res       Date:  2015-08-31       Impact factor: 4.164

8.  Novel test of motor and other dysfunctions in mouse neurological disease models.

Authors:  Albert M I Barth; Istvan Mody
Journal:  J Neurosci Methods       Date:  2013-10-17       Impact factor: 2.390

9.  Controlled Cortical Impact in the Rat.

Authors:  Dana D Dean; Joseph A Frank; L Christine Turtzo
Journal:  Curr Protoc Neurosci       Date:  2017-10-23

10.  HLA-DR3-DQ2 mice do not develop ataxia in the presence of high titre anti-gliadin antibodies.

Authors:  Volga Tarlac; Louise Kelly; Nupur Nag; Judy Allen-Graham; Robert P Anderson; Elsdon Storey
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.